AP2009004849A0 - Pyrazole analogs - Google Patents

Pyrazole analogs

Info

Publication number
AP2009004849A0
AP2009004849A0 AP2009004849A AP2009004849A AP2009004849A0 AP 2009004849 A0 AP2009004849 A0 AP 2009004849A0 AP 2009004849 A AP2009004849 A AP 2009004849A AP 2009004849 A AP2009004849 A AP 2009004849A AP 2009004849 A0 AP2009004849 A0 AP 2009004849A0
Authority
AP
ARIPO
Prior art keywords
pyrazole analogs
pyrazole
analogs
Prior art date
Application number
AP2009004849A
Other languages
English (en)
Inventor
Matthew J Graneto
Todd Michael Maddux
Jamie Masferrer
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AP2009004849A0 publication Critical patent/AP2009004849A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AP2009004849A 2006-11-27 2007-11-14 Pyrazole analogs AP2009004849A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86733706P 2006-11-27 2006-11-27
PCT/IB2007/003518 WO2008065493A1 (fr) 2006-11-27 2007-11-14 Analogues du pyrazole

Publications (1)

Publication Number Publication Date
AP2009004849A0 true AP2009004849A0 (en) 2009-06-30

Family

ID=39226772

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009004849A AP2009004849A0 (en) 2006-11-27 2007-11-14 Pyrazole analogs

Country Status (32)

Country Link
US (1) US7772269B2 (fr)
EP (1) EP2097407A1 (fr)
JP (1) JP4469924B2 (fr)
KR (1) KR20090074264A (fr)
CN (1) CN101541790A (fr)
AP (1) AP2009004849A0 (fr)
AR (1) AR063924A1 (fr)
AU (1) AU2007327004A1 (fr)
BR (1) BRPI0718672A2 (fr)
CA (1) CA2667566C (fr)
CL (1) CL2007003403A1 (fr)
CO (1) CO6180447A2 (fr)
CR (1) CR10745A (fr)
CU (1) CU23801B7 (fr)
DO (1) DOP2009000121A (fr)
EA (1) EA016588B1 (fr)
EC (1) ECSP099328A (fr)
GE (1) GEP20125386B (fr)
GT (1) GT200700104A (fr)
HN (1) HN2007000505A (fr)
IL (1) IL198412A0 (fr)
MA (1) MA30924B1 (fr)
MX (1) MX2009005526A (fr)
NO (1) NO20092413L (fr)
NZ (1) NZ576376A (fr)
PE (1) PE20081299A1 (fr)
RS (1) RS20090211A (fr)
TN (1) TN2009000205A1 (fr)
TW (1) TW200831495A (fr)
UA (1) UA92833C2 (fr)
UY (1) UY30743A1 (fr)
WO (1) WO2008065493A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100072090A (ko) 2007-11-26 2010-06-29 화이자 인코포레이티드 5-ｌｏ 억제제로서의 피라졸 유도체
EP2151450A1 (fr) * 2008-07-29 2010-02-10 Sandoz AG Procédé de préparation d'oligopeptides cycliques microbiologiques
EP2563359A1 (fr) * 2010-04-30 2013-03-06 Allergan, Inc. Nouveau traitement pour la dégénérescence maculaire liée à l'âge et la maladie ischémique oculaire associée à l'activation du complément par le ciblage de la 5-lipoxygénase
TWI527809B (zh) * 2011-01-24 2016-04-01 百靈佳殷格翰國際股份有限公司 作為ｃｒｔｈ２拮抗劑之吡唑化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
CN1050840C (zh) 1993-06-14 2000-03-29 美国辉瑞有限公司 咪唑脂氧合酶抑制剂
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
JP3400392B2 (ja) * 1994-10-18 2003-04-28 ファイザー製薬株式会社 ５−リポキシゲナーゼ阻害剤及び新規医薬組成物
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
WO1997011079A1 (fr) 1995-09-18 1997-03-27 Pfizer Pharmaceuticals Inc. Nouveaux inhibiteurs de l'imidazole lipoxygenase
US6194585B1 (en) * 1998-12-22 2001-02-27 Pfizer Inc. Process for preparing 5-lipoxygenase inhibitors
JP2001100682A (ja) * 1999-09-28 2001-04-13 Sanyo Electric Co Ltd サインシステム
JP2001100686A (ja) * 1999-09-28 2001-04-13 Hitachi Kokusai Electric Inc 表示データ取込方法及び比較検査装置

Also Published As

Publication number Publication date
TN2009000205A1 (fr) 2010-10-18
RS20090211A (en) 2010-10-31
CU23801B7 (es) 2012-03-15
GEP20125386B (en) 2012-01-25
IL198412A0 (en) 2010-02-17
CA2667566C (fr) 2012-01-03
CR10745A (es) 2009-05-22
AR063924A1 (es) 2009-02-25
UY30743A1 (es) 2008-07-03
WO2008065493A1 (fr) 2008-06-05
NO20092413L (no) 2009-07-20
PE20081299A1 (es) 2008-09-17
JP4469924B2 (ja) 2010-06-02
JP2010511601A (ja) 2010-04-15
CN101541790A (zh) 2009-09-23
HN2007000505A (es) 2010-06-09
DOP2009000121A (es) 2009-06-15
EP2097407A1 (fr) 2009-09-09
CL2007003403A1 (es) 2008-07-04
CU20090083A7 (es) 2011-09-21
MA30924B1 (fr) 2009-11-02
CA2667566A1 (fr) 2008-06-05
MX2009005526A (es) 2009-06-05
NZ576376A (en) 2011-02-25
GT200700104A (es) 2011-04-13
EA016588B1 (ru) 2012-06-29
CO6180447A2 (es) 2010-07-19
ECSP099328A (es) 2009-06-30
UA92833C2 (en) 2010-12-10
KR20090074264A (ko) 2009-07-06
EA200970422A1 (ru) 2009-12-30
US7772269B2 (en) 2010-08-10
US20080125474A1 (en) 2008-05-29
AU2007327004A1 (en) 2008-06-05
BRPI0718672A2 (pt) 2013-11-26
TW200831495A (en) 2008-08-01

Similar Documents

Publication Publication Date Title
HK1130780A1 (en) Pyrazoles as 11-beta-hsd-1
EP2166849A4 (fr) Composés pyrazole substitués
ZA201100471B (en) Pyrazole compounds 436
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
EP1984379A4 (fr) Composes anti-arenaviridae
IL192799A0 (en) Substituted 4-phenylpiperidines
EP2084135A4 (fr) Pyrazoles
EP2082022A4 (fr) Composés
IL198412A0 (en) Pyrazole analogs
GB0612420D0 (en) Compounds
ZA200903382B (en) Substituted 4-imidazoles
EP2004174A4 (fr) Composés de naphtalènedione
GB0614037D0 (en) Compounds
GB0602042D0 (en) Compounds
EP1973905A4 (fr) Composes
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP2016069A4 (fr) Composé de bis-pyridine
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
ZA200807959B (en) Pyrazoles as 11-Beta-HSD-1
GB0617866D0 (en) Jarjar (jaropener)
GB0605449D0 (en) 4c
HU0600193V0 (en) Latch-cover for water-network